Overview
Markus Hahn practices in Tuebingen, Germany. Mr. Hahn is rated as an Experienced expert by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Fibroadenoma, Breast Cancer, Breast Cancer in Men, Mastectomy, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 143 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Metastatic Brain Tumor.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerMr. Hahn isDistinguished. Learn about Breast Cancer.
- FibroadenomaMr. Hahn isDistinguished. Learn about Fibroadenoma.
- Advanced
- Breast Cancer in MenMr. Hahn isAdvanced. Learn about Breast Cancer in Men.
- MastectomyMr. Hahn isAdvanced. Learn about Mastectomy.
- Experienced
- Bone Marrow AspirationMr. Hahn isExperienced. Learn about Bone Marrow Aspiration.
- Brain TumorMr. Hahn isExperienced. Learn about Brain Tumor.
- BRCA Positive Breast CancerMr. Hahn isExperienced. Learn about BRCA Positive Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Mr. Hahn isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Hahn isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Mr. Hahn isExperienced. Learn about Chronic Myelogenous Leukemia (CML).